The Complex Interplay of Prescription Drug Monitoring Programs, Regulated Medical Cannabis, and Chronic Pain Healthcare Visits.
作者信息
Albo Boaz, Amital Howard
机构信息
The Medical Cannabis Treatment and Clinical Research Center, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.
Department of Medicine 'B' & The Zabludowiz Center of Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel.
出版信息
J Gen Intern Med. 2025 Apr;40(5):1028-1029. doi: 10.1007/s11606-024-09294-5.
Abstract
摘要
相似文献
1
The Complex Interplay of Prescription Drug Monitoring Programs, Regulated Medical Cannabis, and Chronic Pain Healthcare Visits.处方药监测计划、受监管的医用大麻与慢性疼痛医疗就诊之间的复杂相互作用。
J Gen Intern Med. 2025 Apr;40(5):1028-1029. doi: 10.1007/s11606-024-09294-5.
2
The Combined Relationship of Prescription Drug Monitoring Program Enactment and Medical Cannabis Laws with Chronic Pain-Related Healthcare Visits.处方药监测计划的制定与医用大麻法律与慢性疼痛相关医疗就诊的综合关系。
J Gen Intern Med. 2025 Apr;40(5):1030-1038. doi: 10.1007/s11606-024-09053-6. Epub 2024 Oct 1.
3
Impact of medical and recreational cannabis laws on inpatient visits for asthma.医用和消遣用大麻法律对哮喘住院就诊的影响。
Health Serv Res. 2025 Jun;60(3):e14427. doi: 10.1111/1475-6773.14427. Epub 2024 Dec 30.
4
The role of prescription opioid and cannabis supply policies on opioid overdose deaths.处方阿片类药物和大麻供应政策对阿片类药物过量死亡的作用。
Am J Epidemiol. 2025 Mar 4;194(3):791-801. doi: 10.1093/aje/kwae210.
5
Dose of Exercise Therapy Among Active Duty Soldiers With Chronic Pain Is Associated With Lower Risk of Long-Term Adverse Outcomes After Linking to the Veterans Health Administration.与退伍军人健康管理局建立联系后，慢性疼痛现役军人的运动疗法剂量与长期不良后果风险较低相关。
Mil Med. 2022 Mar 21;188(7-8):e1948-56. doi: 10.1093/milmed/usac074.
6
The prevalence and correlates of self-reported cannabis use for medicinal, dual and recreational motives in Australia: Findings from the National Drug Strategy Household Survey 2022/2023.澳大利亚出于药用、两用和娱乐目的自我报告使用大麻的流行情况及其相关因素：2022/2023年国家毒品战略家庭调查结果
Drug Alcohol Rev. 2025 May 1;44(5):1351-64. doi: 10.1111/dar.14062.
7
The comparative effectiveness of medicinal cannabis for chronic pain versus prescription medication treatment.药用大麻与处方药治疗慢性疼痛的比较疗效。
Pain. 2025 Jan 24;166(7):1631-1640. doi: 10.1097/j.pain.0000000000003506.
8
How prescription drug monitoring programs influence clinical decision-making: A mixed methods systematic review and meta-analysis.处方药物监测计划如何影响临床决策：混合方法系统评价和荟萃分析。
Drug Alcohol Depend. 2021 Nov 1;228:109090. doi: 10.1016/j.drugalcdep.2021.109090. Epub 2021 Sep 22.
9
How to ESCAPE from Pain? An Observational Study on Improving Pain and Quality of Life with the Cannamedical Hybrid Cannabis Extract.如何摆脱疼痛？一项关于使用医用混合型大麻提取物改善疼痛和生活质量的观察性研究。
Adv Ther. 2025 Jun 25. doi: 10.1007/s12325-025-03262-z.
10
Efficacy of Cannabis-Based Medicines for Pain Management: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.基于大麻的药物治疗疼痛的疗效：随机对照试验的系统评价和荟萃分析。
Pain Physician. 2017 Sep;20(6):E755-E796.
本文引用的文献
1
The Combined Relationship of Prescription Drug Monitoring Program Enactment and Medical Cannabis Laws with Chronic Pain-Related Healthcare Visits.处方药监测计划的制定与医用大麻法律与慢性疼痛相关医疗就诊的综合关系。
J Gen Intern Med. 2025 Apr;40(5):1030-1038. doi: 10.1007/s11606-024-09053-6. Epub 2024 Oct 1.
2
A Cross-Sectional Survey Study of Cannabis Use for Fibromyalgia Symptom Management.一项关于大麻用于纤维肌痛症状管理的横断面调查研究。
Mayo Clin Proc. 2024 Apr;99(4):542-550. doi: 10.1016/j.mayocp.2023.12.018.
3
Is Medical Cannabis a Solution for Controlling Fibromyalgia Symptoms?医用大麻是控制纤维肌痛症状的一种解决方案吗？
Mayo Clin Proc. 2024 Apr;99(4):524-526. doi: 10.1016/j.mayocp.2024.02.016.
4
Perspectives of opioid prescribers in overdose hotspots and coldspots, Massachusetts, 2019.2019 年马萨诸塞州毒品泛滥热点地区和冷点地区阿片类药物处方医生的观点。
Subst Use Misuse. 2023;58(8):1069-1074. doi: 10.1080/10826084.2023.2201840. Epub 2023 Apr 19.
5
Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions.临床实践指南：大麻和大麻素类药物在慢性疼痛及共病管理中的应用。
Cannabis Cannabinoid Res. 2024 Apr;9(2):669-687. doi: 10.1089/can.2021.0156. Epub 2023 Mar 27.
6
The effect of cancer exemption in mandatory-access prescription drug monitoring programs among oncologists.强制性获取处方药物监测项目中对肿瘤医生的癌症豁免的影响。
JNCI Cancer Spectr. 2023 Mar 1;7(2). doi: 10.1093/jncics/pkad006.
7
Risk markers for fatal and non-fatal prescription drug overdose: a meta-analysis.致命和非致命性处方药过量的风险标志物：一项荟萃分析。
Inj Epidemiol. 2017 Dec;4(1):24. doi: 10.1186/s40621-017-0118-7. Epub 2017 Aug 7.
8
How, why, and for whom do emergency medicine providers use prescription drug monitoring programs?急诊医学从业者如何、为何以及为谁使用处方药监测程序？
Pain Med. 2015 Jun;16(6):1122-31. doi: 10.1111/pme.12700. Epub 2015 Feb 17.
Zotero 插件